Your cart is empty.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
- Shop
- The Scene
-
About
About Tecan
Investors
Press Center
People
Publications
- Support
- Contact
- Life Sciences
- Diagnostics
- Partnering
- Language
The Blog
Selected category: CtDNA
Back to overview
Oncology prognostics: Why analyzing circulating cell free tumor DNA matters
By Nicholas Smith
We may well be on the threshold of a new hope for oncology. Shorthanded to ctDNA, circulating cell free tumor DNA is sloughed off from tumors. It can be detected in liquid biopsies of just a few milliliters of blood. This could revolutionize what oncology can achieve by diagnosing cancers earlier and more efficiently.